Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

1-(2'-Bromobenzyl)-6,7-dihydroxy-N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D2 Dopamine Receptors.

Silva AG, Vila L, Marques P, Moreno L, Loza M, Sanz MJ, Cortes D, Castro M, Cabedo N.

J Nat Prod. 2020 Jan 24;83(1):127-133. doi: 10.1021/acs.jnatprod.9b00921. Epub 2020 Jan 14.

PMID:
31933369
2.

Micronuclei Detection by Flow Cytometry as a High-Throughput Approach for the Genotoxicity Testing of Nanomaterials.

García-Rodríguez A, Kazantseva L, Vila L, Rubio L, Velázquez A, Ramírez MJ, Marcos R, Hernández A.

Nanomaterials (Basel). 2019 Nov 24;9(12). pii: E1677. doi: 10.3390/nano9121677.

3.

Synthesis of benzopyran derivatives as PPARα and/or PPARγ activators.

Bermejo A, Barrachina I, El Aouad N, Franck X, Chahboune N, Andreu I, Figadère B, Vila L, Hennuyer N, Staels B, Dacquet C, Caignard DH, Sanz MJ, Cortes D, Cabedo N.

Bioorg Med Chem. 2019 Dec 15;27(24):115162. doi: 10.1016/j.bmc.2019.115162. Epub 2019 Oct 30.

PMID:
31703893
4.

The Comet Assay as a Tool to Detect the Genotoxic Potential of Nanomaterials.

García-Rodríguez A, Rubio L, Vila L, Xamena N, Velázquez A, Marcos R, Hernández A.

Nanomaterials (Basel). 2019 Sep 27;9(10). pii: E1385. doi: 10.3390/nano9101385.

5.

A multidisciplinary approach for patients with multiple chronic conditions: IMPACTO study.

Nieto-Martín MD, De la Higuera-Vila L, Bernabeu-Wittel M, González-Benitez MA, Alfaro-Lara ER, Barón-Ramos MA, Montero-Aparicio E, Aparicio-Santos R, Baturone MO; list of researchers involved in the IMPACTO study and their affiliations.

Med Clin (Barc). 2019 Aug 2;153(3):93-99. doi: 10.1016/j.medcli.2019.01.014. Epub 2019 Mar 8. English, Spanish.

PMID:
30857796
6.

Synthesis and biological evaluation of sphingosine kinase 2 inhibitors with anti-inflammatory activity.

Vettorazzi M, Vila L, Lima S, Acosta L, Yépes F, Palma A, Cobo J, Tengler J, Malik I, Alvarez S, Marqués P, Cabedo N, Sanz MJ, Jampilek J, Spiegel S, Enriz RD.

Arch Pharm (Weinheim). 2019 Mar;352(3):e1800298. doi: 10.1002/ardp.201800298. Epub 2019 Jan 16.

PMID:
30648282
7.

Effects of differently shaped TiO2NPs (nanospheres, nanorods and nanowires) on the in vitro model (Caco-2/HT29) of the intestinal barrier.

García-Rodríguez A, Vila L, Cortés C, Hernández A, Marcos R.

Part Fibre Toxicol. 2018 Aug 7;15(1):33. doi: 10.1186/s12989-018-0269-x.

8.

Ethical Challenges of Early Identification of Advanced Chronic Patients in Need of Palliative Care: The Catalan Experience.

Gómez-Batiste X, Blay C, Broggi MA, Lasmarias C, Vila L, Amblàs J, Espaulella J, Costa X, Martínez-Muñoz M, Robles B, Quintana S, Bertran J, Torralba F, Benito C, Terribas N, Busquets JM, Constante C.

J Palliat Care. 2018 Oct;33(4):247-251. doi: 10.1177/0825859718788933. Epub 2018 Jul 13.

PMID:
30001656
9.

Titanium dioxide nanoparticles translocate through differentiated Caco-2 cell monolayers, without disrupting the barrier functionality or inducing genotoxic damage.

Vila L, García-Rodríguez A, Marcos R, Hernández A.

J Appl Toxicol. 2018 Sep;38(9):1195-1205. doi: 10.1002/jat.3630. Epub 2018 May 3.

PMID:
29722448
10.

Assessing the effects of silver nanoparticles on monolayers of differentiated Caco-2 cells, as a model of intestinal barrier.

Vila L, García-Rodríguez A, Cortés C, Marcos R, Hernández A.

Food Chem Toxicol. 2018 Jun;116(Pt B):1-10. doi: 10.1016/j.fct.2018.04.008. Epub 2018 Apr 4.

PMID:
29626574
11.

Exploring the usefulness of the complex in vitro intestinal epithelial model Caco-2/HT29/Raji-B in nanotoxicology.

García-Rodríguez A, Vila L, Cortés C, Hernández A, Marcos R.

Food Chem Toxicol. 2018 Mar;113:162-170. doi: 10.1016/j.fct.2018.01.042. Epub 2018 Feb 2.

PMID:
29421767
12.

Effects of cerium oxide nanoparticles on differentiated/undifferentiated human intestinal Caco-2 cells.

Vila L, García-Rodríguez A, Cortés C, Velázquez A, Xamena N, Sampayo-Reyes A, Marcos R, Hernández A.

Chem Biol Interact. 2018 Mar 1;283:38-46. doi: 10.1016/j.cbi.2018.01.018. Epub 2018 Jan 31.

PMID:
29378162
13.

[Find your 1%: prevalence and mortality of a community cohort of people with advanced chronic disease and palliative needs].

Blay C, Martori JC, Limón E, Oller R, Vila L, Gómez-Batiste X.

Aten Primaria. 2019 Feb;51(2):71-79. doi: 10.1016/j.aprim.2017.07.004. Epub 2017 Nov 20. Spanish.

14.

Long-term effects of silver nanoparticles in caco-2 cells.

Vila L, Marcos R, Hernández A.

Nanotoxicology. 2017 Aug;11(6):771-780. doi: 10.1080/17435390.2017.1355997. Epub 2017 Jul 26.

PMID:
28707555
15.

Frozen dispersions of nanomaterials are a useful operational procedure in nanotoxicology.

Vila L, Rubio L, Annangi B, García-Rodríguez A, Marcos R, Hernández A.

Nanotoxicology. 2017 Feb;11(1):31-40. doi: 10.1080/17435390.2016.1262918. Epub 2016 Dec 1.

PMID:
27855561
16.

Utility of the NECPAL CCOMS-ICO© tool and the Surprise Question as screening tools for early palliative care and to predict mortality in patients with advanced chronic conditions: A cohort study.

Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X, Espaulella J, Villanueva A, Oller R, Martori JC, Constante C.

Palliat Med. 2017 Sep;31(8):754-763. doi: 10.1177/0269216316676647. Epub 2016 Nov 4.

PMID:
27815556
17.

[Living with advanced chronic obstructive pulmonary disease: The impact of dyspnoea on patients and caregivers].

Costa X, Gómez-Batiste X, Pla M, Martínez-Muñoz M, Blay C, Vila L.

Aten Primaria. 2016 Dec;48(10):665-673. doi: 10.1016/j.aprim.2016.02.008. Epub 2016 Jun 7. Spanish.

18.

The Catalonia WHO Demonstration Project of Palliative Care: Results at 25 Years (1990-2015).

Gómez-Batiste X, Blay C, Martínez-Muñoz M, Lasmarías C, Vila L, Espinosa J, Costa X, Sánchez-Ferrin P, Bullich I, Constante C, Kelley E.

J Pain Symptom Manage. 2016 Jul;52(1):92-9. doi: 10.1016/j.jpainsymman.2015.11.029. Epub 2016 May 24.

19.

Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system.

Rubio L, Annangi B, Vila L, Hernández A, Marcos R.

Arch Toxicol. 2016 Feb;90(2):269-78. doi: 10.1007/s00204-015-1468-y. Epub 2015 Jan 25.

PMID:
25618551
20.

Identifying patients with chronic conditions in need of palliative care in the general population: development of the NECPAL tool and preliminary prevalence rates in Catalonia.

Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X, Villanueva A, Espaulella J, Espinosa J, Figuerola M, Constante C.

BMJ Support Palliat Care. 2013 Sep;3(3):300-8. doi: 10.1136/bmjspcare-2012-000211. Epub 2012 Dec 15.

PMID:
24644748

Supplemental Content

Loading ...
Support Center